Comprehensive transition of care for polycystic ovary syndrome from adolescence to adulthood
- PMID: 38552655
- PMCID: PMC11837223
- DOI: 10.1016/S2352-4642(24)00019-1
Comprehensive transition of care for polycystic ovary syndrome from adolescence to adulthood
Abstract
Polycystic ovary syndrome (PCOS) is a lifelong chronic condition that affects one in ten females and can be diagnosed in adolescence. As adolescents with PCOS transition to adulthood, counselling for lifestyle management and mental health concerns often transition from involving the family unit to increasingly individual-focused approaches. PCOS is associated with a large range of comorbidities affecting reproductive, metabolic, dermatological, and psychological health. The diagnosis and comorbidities of PCOS are influenced by pubertal hormones and need to be reassessed continuously to ensure that treatment remains appropriate for age and development. As young patients grow up, personal concerns often change, especially in relation to reproductive management. In this Review, we present prevalence rates, screening tools, and treatment recommendations for PCOS-related conditions, and we consider the diagnostic and clinical elements of optimal transition of care models that ensure continuity of comprehensive care for adolescents moving from the paediatric health-care system to the adult health-care system.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests SLS is an unpaid board member of the board of directors of the Society of Behavioral Sleep Medicine. PP-B declares honoraria for speaking for the West Virginia Area Health Education; The Menopause and Minority Health Project. LDG declares honoraria for speaking from the American Diabetes Association. JMM declares a contract between her institution and Nestle Health Science that provides a Nestle product at price (with no profit margin) to patients at a weight management programme at the University of Colorado; she received honoraria for speaking from the University of Massachusetts and the University of Minnesota; is an unpaid board member of the American Society for Metabolic and Bariatric Surgery and the Obesity Society; and has submitted a proposal requesting in-kind donations from Novo Nordisk within the company's investigator-sponsored grants programme. MGC received consulting fees from Pollie and donations of amino acid and placebo drinks from Amino Co; and is Co-President of the PCOS special interest group of the Pediatric Endocrine Society. All other authors declare no competing interests.
Figures
References
-
- Teede HJ, Tay CT, Laven JJE, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. The Journal of clinical endocrinology and metabolism. Sep 18 2023;108(10):2447–2469. doi:10.1210/clinem/dgad463 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
